REAP Financial Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.5K Buy
230
+2
+0.9% +$526 0.01% 263
2026
Q1
$60.9K Buy
228
+10
+5% +$2.71K 0.01% 265
2025
Q4
$54.7K Buy
218
+37
+20% +$9.83K 0.01% 285
2025
Q3
$51.9K Buy
181
+14
+8% +$3.75K 0.01% 265
2025
Q2
$43.7K Buy
167
+110
+193% +$26.8K 0.01% 279
2025
Q1
$13.4K Sell
57
-7
-11% -$1.7K ﹤0.01% 344
2024
Q4
$14.6K Hold
64
﹤0.01% 322
2024
Q3
$14.2K Buy
64
+3
+5% +$659 ﹤0.01% 315
2024
Q2
$12.5K Sell
61
-3
-5% -$610 ﹤0.01% 310
2024
Q1
$14.1K Buy
64
+2
+3% +$441 ﹤0.01% 331
2023
Q4
$14.1K Buy
+62
New +$13K ﹤0.01% 363

Other funds holding LH

REAP Financial Group's LH Position: Q2 2026 in Review

REAP Financial Group increased its Labcorp (LH) stake by 0.88% in Q2 2026, buying an estimated $526 and bringing the position to 230 shares worth $64.5K. The position accounts for 0.01% of the portfolio, ranked #263.

REAP Financial Group first reported a position in LH in Q4 2023 and has held it in 11 quarters since. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • REAP Financial Group held 230 shares of Labcorp worth $64.5K as of Q2 2026.
  • REAP Financial Group bought 2 Labcorp shares in Q2 2026, an estimated $526.
  • Labcorp made up 0.01% of REAP Financial Group's portfolio in Q2 2026, its #263 holding.
  • REAP Financial Group first reported a position in Labcorp in Q4 2023 and has held it in 11 quarters since.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on REAP Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.